MS Newbies: Recently Approved and Pipeline Drugs for the Treatment of Multiple Sclerosis Webcast is organized by AchieveCE.

Release Date: 11/22/2021
Expiration Date: 11/22/2024

About this course:
The field of Multiple Sclerosis is ever-changing, with new targets and biomarkers being discovered each year. It can be challenging to stay up to date on newly approved agents given so many different components that play a role in treatment of Multiple Sclerosis. This activity will review the newest FDA-approved Multiple Sclerosis treatment agents including efficacy and safety features. This activity will also provide clinicians with drug/patient characteristics that are critical for appropriate treatment selection and recommendations.

What you’ll learn:
Pharmacist Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:

Discuss the mechanism of action of newly approved MS treatments
Discuss the mechanism of action of pipeline multiple sclerosis treatments
Discuss literature to date for approval of new agents and pending trials for pipeline MS treatments

Nurse / Pharmacy Technician Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:

Review the mechanism of action of newly approved MS treatments
Review how pipeline multiple sclerosis treatments work
Discuss literature to date for approval of new agents and pending trials for pipeline MS treatments